Published On: Wed, Oct 19th, 2016

Lumenis Ltd. (NASDAQ:LMNS) Updated Analyst Coverage


A number of investment brokers have recently updated their price targets on shares of Lumenis Ltd. (NASDAQ:LMNS).

Most recent broker ratings

06/19/2015 – Lumenis Ltd. was downgraded to “underperform” by analysts at Credit Suisse. They now have a USD 14 price target on the stock.

06/19/2015 – Lumenis Ltd. was downgraded to “hold” by analysts at Jefferies. They now have a USD 14 price target on the stock.

06/18/2015 – Lumenis Ltd. was downgraded to “hold” by analysts at Maxim Group. They now have a USD 14 price target on the stock.

06/18/2015 – Lumenis Ltd. was downgraded to “market perform” by analysts at Wells Fargo.

05/14/2015 – Lumenis Ltd. was downgraded to “sell” by analysts at Zacks.

04/08/2014 – Goldman Sachs began new coverage on Lumenis Ltd. giving the company a “buy” rating. They now have a USD 17 price target on the stock.

The share price of Lumenis Ltd. (NASDAQ:LMNS) was up +0.00% during the last day of trading, with a day high of 0.00. 0 shares were traded during the last session.

The stock’s 50 day moving average is 13.80 and its 200 day moving average is 12.89.Lumenis Ltd. has a 52-week low of 8.45 and a 52-week high of 13.97.

Lumenis Ltd. (Lumenis) is a provider of energy-based, minimally invasive clinical solutions. The Company operates through three segments: surgical, ophthalmic and aesthetic. The Company offers energy-based solutions for medically necessary and elective procedures, primarily for the aging population. Its solutions include the holmium laser, the Lumenis Pulse 120H, used for urologic applications; the VersaPulse PowerSuite platform which uses holmium lasers for urologic applications; the M22 multi-energy, a multi-application platform for the treatment of various skin conditions, and the Selecta multi-modality platform for retinal, secondary cataract and glaucoma therapies. It offers products to hospitals, outpatient clinics, ambulatory surgery centers, physicians’ offices, private clinics and aesthetic chains. Its locations include Yokneam, Israel, where surgical and aesthetic products are manufactured, and Salt Lake City, Utah, where ophthalmic products are manufactured.